PSDV - pSivida Limited Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited

PSDV 1.220

+14.0%

Mar 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (341)	12/23/2010 10:57:02 PM
From: John McCarthy	of 421

Hi Arthur I just saw your note and have just begun to read the BAD news. To put it mildly - I am stunned. Worst - I left alot on the table as my avg cost was below 3.00. So I am pissed at myself. (I've done this before -g-) I did note this after a 10 second read: In the CRL, the FDA asked for analyses of safety and efficacy data through month 36 of the FAME Study Alimera has completed month 36 of the FAME Study and has reported that it is preparing the analyses that the FDA has requested The FDA did not ask for any new clinical studies in the CRL.** finance.yahoo.com QUESTION TO YOU: If they did not request any new trial - does that imply that there is NO CHANCE for this? IOW - do you have any prior experience with this type of scenario. (I am use to ... do more trials yada yada yada.) regards John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next